全文获取类型
收费全文 | 29867篇 |
免费 | 2126篇 |
国内免费 | 145篇 |
专业分类
耳鼻咽喉 | 93篇 |
儿科学 | 1664篇 |
妇产科学 | 688篇 |
基础医学 | 2752篇 |
口腔科学 | 117篇 |
临床医学 | 2968篇 |
内科学 | 9468篇 |
皮肤病学 | 501篇 |
神经病学 | 2359篇 |
特种医学 | 247篇 |
外科学 | 3232篇 |
综合类 | 699篇 |
现状与发展 | 1篇 |
一般理论 | 6篇 |
预防医学 | 2622篇 |
眼科学 | 1040篇 |
药学 | 1248篇 |
2篇 | |
中国医学 | 62篇 |
肿瘤学 | 2369篇 |
出版年
2024年 | 44篇 |
2023年 | 280篇 |
2022年 | 261篇 |
2021年 | 394篇 |
2020年 | 371篇 |
2019年 | 149篇 |
2018年 | 551篇 |
2017年 | 561篇 |
2016年 | 646篇 |
2015年 | 632篇 |
2014年 | 530篇 |
2013年 | 845篇 |
2012年 | 2385篇 |
2011年 | 2651篇 |
2010年 | 916篇 |
2009年 | 889篇 |
2008年 | 2766篇 |
2007年 | 2645篇 |
2006年 | 2281篇 |
2005年 | 2399篇 |
2004年 | 2426篇 |
2003年 | 2531篇 |
2002年 | 1957篇 |
2001年 | 1438篇 |
2000年 | 324篇 |
1999年 | 167篇 |
1998年 | 227篇 |
1997年 | 137篇 |
1996年 | 103篇 |
1995年 | 64篇 |
1994年 | 78篇 |
1993年 | 43篇 |
1992年 | 44篇 |
1991年 | 36篇 |
1990年 | 42篇 |
1989年 | 37篇 |
1988年 | 40篇 |
1987年 | 39篇 |
1986年 | 33篇 |
1985年 | 25篇 |
1984年 | 25篇 |
1983年 | 13篇 |
1982年 | 20篇 |
1981年 | 22篇 |
1980年 | 13篇 |
1979年 | 9篇 |
1978年 | 10篇 |
1975年 | 5篇 |
1974年 | 6篇 |
1970年 | 6篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
31.
32.
Solish Nowell MD Benohanian Antranik MD Jonathan W. Kowalski PharmD MS on Behalf of the Canadian Dermatology Study Group on Health-Related Quality of Life in Primary Axillary Hyperhidrosis 《Dermatologic surgery》2005,31(4):405-413
BACKGROUND: Patients with primary axillary hyperhidrosis experience substantial functional impairment and reduced health-related quality of life (HRQOL). Few studies have comprehensively evaluated the effects of botulinum toxin type A (BoNT-A) on these symptoms. OBJECTIVE: To prospectively assess the effects of BoNT-A on functional impairment associated with primary axillary hyperhidrosis. METHODS: Patients treated with BoNT-A 50 U per axilla at baseline were assessed 4 and 12 weeks later. Outcome measures included functional impairment as assessed by the Hyperhidrosis Disease Severity Scale and the Hyperhidrosis Impact Questionnaire and dermatology-specific HRQOL as assessed by the Dermatology Life Quality Index. RESULTS: At weeks 4 and 12 after BoNT-A treatment, 85% and 90% of patients achieved the a priori definition of treatment responder. Patients reported less occupational and emotional impairment, spent less time managing their hyperhidrosis, and had fewer difficulties in social situations. Adverse events were uncommon (5.5%), were mild, and did not require treatment. At study end, 53% of patients reported no dermatology-specific HRQOL impairment and 90% were satisfied with treatment. CONCLUSIONS: Significant, meaningful, rapid, and durable reductions in disease severity and functional impairment, as well as improvements in HRQOL, were seen following BoNT-A treatment. BoNT-A was safe and well tolerated, producing high levels of patient satisfaction. 相似文献
33.
Frank Makowiec Stefan Post Hans-Detlev Saeger Norbert Senninger Heinz Becker Michael Betzler Heinz J. Buhr Ulrich T. Hopt German Advanced Surgical Treatment Study Group 《Journal of gastrointestinal surgery》2005,9(8):1080-1087
Despite decreasing mortality rates, morbidity is still high after pancreatic head resection. Comparative data in the United
States and Europe show a relationship between hospital volume and mortality. Treatment strategies vary frequently, partially
because of the lack of evidence-based data. We performed a multi-institutional analysis in Germany evaluating current numbers,
indications, techniques, and complication rates of pancreatic head resection. Questionnaires were completed by seven high-volume
surgical departments regarding quantitative and qualitative aspects of pancreatic head resections in the period from 1999
to 2004 (five prospective and two retrospective institutional databases). A total of 1454 pancreatic head resections (944
for malignancy) were reported. Mean annual hospital volume ranged from 14 to 52 (10 to 43 in malignancy). Mortality was between
1.1% and 4.8%, morbidity was between 24% and 46%, and pancreatic leakage was between 9% and 20%. In malignant disease, all
centers perform standard lymphadenectomy and regard arterial infiltration as a contraindication for resection. However, the
rate of portal vein resection varied from 0% to 28%. No consensus is seen on the type of surgery for malignancy and chronic
pancreatitis. After resection for pancreatic cancer less than one fourth of the patients receive adjuvant therapy. The results
of our analysis in Germany confirm that pancreatic head resection can be performed with low mortality in specialized units.
Variations in indications, operative technique, and perioperative care may demonstrate the lack of evidence-based data and/or
personal and institutional experience. The low number of patients receiving adjuvant therapy after resection of pancreatic
cancer suggests that more efforts must be made to establish novel adjuvant therapies under randomized study conditions.
Presented at the Forty-Sixth Annual Meeting of The Society for Surgery of the Alimentary Tract, Chicago, Illinois, May 14–18,
2005 (oral presentation). 相似文献
34.
Fernandez-Aviles Francisco; Sanchez Pedro L.; On behalf of the GRACIA Group 《European heart journal》2007,28(19):2418
We thank Dr Villata et al. for their thought-provoking comments.Their concern about the suitableness to choose combined endpointsin clinical trials deserves some comment. 相似文献
35.
36.
Claus Neurohr Patrick Huppmann Hanno Leuchte Martin Schwaiblmair Iris Bittmann Gundula Jaeger Rudolf Hatz Lorenz Frey Peter Überfuhr Bruno Reichart Jürgen Behr for the Munich Lung Transplant Group 《American journal of transplantation》2005,5(12):2982-2991
Bronchiolitis obliterans syndrome (BOS) is the limiting factor to long-term survival after lung transplantation. Previous studies suggested respiratory viral tract infections are associated with the development of BOS. To identify the impact of virus detection in bronchoalveolar lavage (BAL) fluid, we analyzed BAL samples from 87 consecutive lung transplant recipients for human herpesvirus (HHV)-6, Epstein-Barr virus, Herpes simplex virus 1/2, Cytomegalovirus, respiratory syncytical virus and adenovirus by PCR. Acute rejection, BOS and death were recorded for a mean follow-up time of 3.27 +/- 0.47 years. Results of PCR analysis and other potential risk factors were entered into a Cox regression analysis of BOS predictors and death. Only acute rejection was a distinct risk factor for BOS of all stages, death and death from BOS. HHV-6 was detected in 20 patients. Univariate and multivariate analysis revealed that HHV-6 was associated with an increased risk to develop BOS > orb = stage 1 and death, separate from the risk attributable to acute rejection. Identification of HHV-6 DNA in BAL fluid is a potential risk factor for BOS. Our results warrant further studies to elucidate a possible causal link between HHV-6 and BOS. 相似文献
37.
38.
研究地西泮、苯巴比妥、普萘洛尔和西咪替丁对地西泮氧化代谢的影响及其药酶蛋白的初步分析,应用HPLC,SDS聚丙烯酰胺凝胶电泳和薄层扫描测定地西泮及其代谢物,并对大鼠肝微粒体和酶蛋白进行分离和含量测定。结果表明地西泮、普萘洛尔和西咪替丁使肝微粒体中P450含量明显降低。地西泮和普萘洛尔明显抑制地西泮C3羟化活性,大剂量普萘洛尔尚能抑制地西泮N脱甲基。苯巴比妥明显诱导P450生成,增强地西泮N脱甲基和C3羟化酶活性及分子量为51,000和59,000的电泳蛋白带,而地西泮、普萘洛尔则呈抑制作用。并发现,地西泮N脱甲基酶活性和分子量为59,000蛋白含量呈线性相关(P<0.05),而C3羟化酶活性则与51,000蛋白含量呈线性相关(P<0.01)。因此地西泮C3羟化代谢可能与51,000的P450酶蛋白有关,而N脱甲基代谢则可能与59,000的P450酶蛋白有关。 相似文献
39.
WHO Working Group 《Bulletin of the World Health Organization》1986,64(4):481-492
Chlamydia trachomatis, the causative agent of trachoma, affecting hundreds of millions of people, is now recognized as a major cause of sexually transmitted disease. In many countries chlamydial infection now outstrips gonorrhoea as the major cause of genital tract infection. Chlamydial urethritis and cervicitis are frequently complicated by ascending infection involving the endometrium, the fallopian tubes and epididymis. This often results in serious reproductive sequelae, e.g., infertility in the female and ectopic pregnancy. Extra-genital manifestations of chlamydial infection may occur involving the eyes (follicular conjunctivitis), joints (arthritis), and distal intestinal tract. Infection of the newborn child during birth may result in ocular or lung disease. 相似文献
40.
河南省传染性非典型肺炎患者胸部X线表现 总被引:1,自引:1,他引:0
目的 :探讨传染性非典型肺炎的X线表现及变化规律。方法 :对河南省临床诊断的 1 5例患者发病后不同时间的系列胸片和CT进行回顾性分析。结果 :1 5例胸部X线病灶初始形态为斑片状 1 1例 (73.3% ) ,大片状 4例 (2 6 .7% ) ;双侧 9例 (6 0 .0 % ) ,单侧 6例 (4 0 .0 % ) ,均为中、下肺野 (1 0 0 % )。动态观察发现病变进展快 ,病变发展到高峰期时间为 4~ 1 4d , x±s(7.7± 3.2 )d ,双侧 1 3例 (86 .7% ) ,单侧 2例 (1 3.3% ) ,两肺叶及两肺叶以上病变者 1 4例 (93.3% )。病变开始吸收时间为 6~ 2 1d , x±s(1 1 .3± 4 .1 )d ;完全或基本吸收时间 8~ 2 6d , x±s(1 6 .4± 5 .0 )d。1 5例经治疗均痊愈出院。住院时间 1 8~ 4 2d , x±s(31 .9± 7.9)d。 结论 :传染性非典型肺炎的胸部X线特点为急性双侧或单侧多叶炎性浸润阴影 ,以中、下野常见 ,进展迅速 ,及时复查胸部X线对临床诊断及判断病情具有重要价值。 相似文献